Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer

Summary

The goals of this clinical research study are to see how individuals with advanced head and neck cancer respond to treatment with the new drug thrombospondin (ABT-510) and to learn how effective it is in destroying cancer cells. The safety of ABT-510 and the effect ABT-510 has on cells in the body will also be studied.

Timeline

Start

2005-04

Primary completion

2008-03

Completion

2008-03

Drugs

Indications